Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Susanne Hauschildt Bendz | M | 66 |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 20 years |
| Jeannett Hvidkjær | F | 58 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| John R. Mowat | M | - |
Arlington Capital Investors Ltd.
 Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 3 years |
| Karl Robertson van Horn | M | 89 |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 3 years |
| Hélène Jelman | F | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 3 years |
| Jesper Ahlmann Funding Andersen | M | 58 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Nathaniel V. Dial | M | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | - |
| Elizabeth Wells | F | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 4 years |
| Caroline Maria Ditlefsen | F | 47 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Søren Østergaard | M | - |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Jakob Brix Christensen | M | - |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 5 years |
| Allan Toft Jacobsen | M | 53 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Kirsten Bakbøl | F | 69 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 12 years |
| Jaime Grego | M | 60 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Audrey L. Welsh | F | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 8 years |
| Flemming Juul Jensen | M | 75 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 11 years |
| Bente V. Jensen | F | 74 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 11 years |
| Jens Harpøth Zilstorff | M | 69 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Flemming Heise Pedersen | M | 59 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
| Jørgen Drejer | M | 69 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | 14 years |
| Geoffrey Bray | M | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 12 years |
| Christine J. M. Morin-Postel | F | 75 |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | - |
| Stephen P. Chance | M | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 11 years |
| Henry C. Blackie | M | - |
Arlington Capital Investors Ltd.
Arlington Capital Investors Ltd. Financial ConglomeratesFinance Arlington Capital Investors Ltd. (Arlington) is the investment management subsidiary of Arlington Capital Management (CI) Ltd. (Guernsey). The firm was founded in 1991 and is based in London. In addition to investing in a limited number of quoted companies around the themes of industrial reform, corporate restructuring and shareholder value, Arlington manages the European Renaissance Fund. | 17 years |
| Desiree Kronevald Ruskol | F | 54 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 15 | 60.00% |
| United Kingdom | 10 | 40.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jens Ulrik Holst
- Personal Network
